{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:32:01Z","timestamp":1776425521186,"version":"3.51.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/2047-9158-2-25","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T16:02:25Z","timestamp":1387468945000},"source":"Crossref","is-referenced-by-count":35,"title":["A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States"],"prefix":"10.1186","volume":"2","author":[{"given":"David A","family":"Geier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian S","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet K","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa K","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R","family":"Geier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,19]]},"reference":[{"key":"50_CR1","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1542\/peds.2010-2989","volume":"127","author":"CA Boyle","year":"2011","unstructured":"Boyle CA, Boulet S, Schieve LA, Cohen RA, Blumberg SJ, Yeargin-Allsopp M, Visser S, Kogan MD: Trends in the prevalence of developmental disabilities in US children, 1997\u20132008. Pediatrics 2011, 127: 1034-1042. 10.1542\/peds.2010-2989","journal-title":"Pediatrics"},{"key":"50_CR2","first-page":"1","volume":"61","author":"Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention","year":"2012","unstructured":"Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention: Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 2012, 61: 1-19.","journal-title":"MMWR Surveill Summ"},{"key":"50_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/19315864.2012.681340","volume":"6","author":"DA Geier","year":"2013","unstructured":"Geier DA, Kern JK, Geier MR: A comparison of the Autism Treatment Evaluation Checklist (ATEC) and the Childhood Autism Rating Scale (CARS) for the quantitative evaluation of autism. J Ment Health Res Intellect Disabil 2013, 6: 255-267. 10.1080\/19315864.2012.681340","journal-title":"J Ment Health Res Intellect Disabil"},{"key":"50_CR4","first-page":"193","volume":"7","author":"DA Geier","year":"2012","unstructured":"Geier DA, Kern JK, Geier MR: A prospective cross-sectional cohort assessment of health, physical, and behavioral problems in autism spectrum disorders. Maedica (Buchar) 2012, 7: 193-200.","journal-title":"Maedica (Buchar)"},{"key":"50_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2047-9158-2-17","volume":"2","author":"JK Kern","year":"2013","unstructured":"Kern JK, Geier DA, Sykes LK, Geier MR: Evidence of neurodegeneration in autism spectrum disorder. Transl Neurodegener 2013, 2: 17. 10.1186\/2047-9158-2-17","journal-title":"Transl Neurodegener"},{"key":"50_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.55782\/ane-2010-1788","volume":"70","author":"MC Desoto","year":"2010","unstructured":"Desoto MC, Hitlan RT: Sorting out the spinning of autism: heavy metals and the question of incidence. Acta Neurobiol Exp (Wars) 2010, 70: 165-176.","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"50_CR7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.55782\/ane-2012-1887","volume":"72","author":"JK Kern","year":"2012","unstructured":"Kern JK, Geier DA, Audhya T, King PG, Sykes LK, Geier MR: Evidence of parallels between mercury intoxication and the brain pathology in autism. Acta Neurobiol Exp (Wars) 2012, 72: 113-153.","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"50_CR8","first-page":"383","volume":"128","author":"DA Geier","year":"2008","unstructured":"Geier DA, King PG, Sykes LK, Geier MR: A comprehensive review of mercury provoked autism. Indian J Med Res 2008, 128: 383-411.","journal-title":"Indian J Med Res"},{"key":"50_CR9","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.3390\/ijerph10083771","volume":"10","author":"JK Kern","year":"2013","unstructured":"Kern JK, Haley BE, Geier DA, Sykes LK, King PG, Geier MR: Thimerosal exposure and the role of sulfation chemistry and thiol availability in autism. Int J Environ Res Public Health 2013, 10: 3771-3800. 10.3390\/ijerph10083771","journal-title":"Int J Environ Res Public Health"},{"key":"50_CR10","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1542\/peds.107.5.1147","volume":"107","author":"LK Ball","year":"2001","unstructured":"Ball LK, Ball R, Pratt RD: An assessment of Thimerosal use in childhood vaccines. Pediatrics 2001, 107: 1147-1154. 10.1542\/peds.107.5.1147","journal-title":"Pediatrics"},{"key":"50_CR11","first-page":"2908","volume":"17","author":"JA Singleton","year":"1999","unstructured":"Singleton JA, Lloyd JC, Mootrey GT, Salive ME, Chen RT: An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine 1999, 17: 2908-2917.","journal-title":"VAERS Working Group. Vaccine"},{"key":"50_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1517\/14656566.5.3.691","volume":"5","author":"DA Geier","year":"2004","unstructured":"Geier DA, Geier MR: A review of the vaccine adverse event reporting system database. Expert Opin Pharmacother 2004, 5: 691-698. 10.1517\/14656566.5.3.691","journal-title":"Expert Opin Pharmacother"},{"key":"50_CR13","first-page":"186","volume":"78","author":"RT Chen","year":"2000","unstructured":"Chen RT, DeStefano F, Davis RL, Jackson LA, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Ward JI, Marcy SM: The vaccine safety datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ 2000, 78: 186-194.","journal-title":"Bull World Health Organ"},{"key":"50_CR14","first-page":"765","volume":"99","author":"RT Chen","year":"1997","unstructured":"Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, March SM, Ward JI, Wise RP, Wassilak SG, Hadler SC: Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics 1997, 99: 765-773.","journal-title":"The Vaccine Safety Datalink Team. Pediatrics"},{"key":"50_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1749-6632.1995.tb44473.x","volume":"754","author":"SG Wassilak","year":"1995","unstructured":"Wassilak SG, Glasser JW, Chen RT, Hadler SC: Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. The Vaccine Safety Datalink Investigators. Ann N Y Acad Sci 1995, 754: 377-382.","journal-title":"The Vaccine Safety Datalink Investigators. Ann N Y Acad Sci"},{"key":"50_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2165\/00002018-200225030-00001","volume":"25","author":"SS Ellenberg","year":"2002","unstructured":"Ellenberg SS, Braun MM: Monitoring the safety of vaccines: assessing the risks. Drug Saf 2002, 25: 145-152. 10.2165\/00002018-200225030-00001","journal-title":"Drug Saf"},{"key":"50_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","volume":"23","author":"F Varricchio","year":"2004","unstructured":"Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT: Understanding vaccine safety information from the vaccine adverse event reporting system. Pediatr Infect Dis J 2004, 23: 287-294. 10.1097\/00006454-200404000-00002","journal-title":"Pediatr Infect Dis J"},{"key":"50_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/00002018-200629050-00002","volume":"29","author":"J Iskander","year":"2006","unstructured":"Iskander J, Pool V, Zhou W, English-Bullard R: VAERS Team. Data mining in the US using the vaccine adverse event reporting system. Drug Saf 2006, 29: 375-384. 10.2165\/00002018-200629050-00002","journal-title":"Drug Saf"},{"key":"50_CR19","unstructured":"Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices MMWR Recomm Rep 1997, 46: 1-25."},{"key":"50_CR20","unstructured":"Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP) MMWR Recomm Rep 1991, 40: 1-25."},{"key":"50_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5271\/sjweh.2239","volume":"11","author":"TW Clarkson","year":"1985","unstructured":"Clarkson TW, Nordberg GF, Sager PR: Reproductive and developmental toxicity of metals. Scan J Work Environ Health 1985, 11: 145-154. 10.5271\/sjweh.2239","journal-title":"Scan J Work Environ Health"},{"key":"50_CR22","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1289\/ehp.7712","volume":"113","author":"TM Burbacher","year":"2005","unstructured":"Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T: Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing Thimerosal. Environ Health Perpsect 2005, 113: 1015-1021. 10.1289\/ehp.7712","journal-title":"Environ Health Perpsect"},{"key":"50_CR23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00204-010-0538-4","volume":"84","author":"JL Rodrigues","year":"2010","unstructured":"Rodrigues JL, JM S i, Batista BL, Souza SS, Barbosa F Jr: Identification and distribution of mercury species in rat tissues following administration of Thimerosal or methylmercury. Arch Toxicol 2010, 84: 891-896. 10.1007\/s00204-010-0538-4","journal-title":"Arch Toxicol"},{"key":"50_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuro.2013.05.015","volume":"38","author":"LT Zimmermann","year":"2013","unstructured":"Zimmermann LT, Santos DB, Naime AA, Leal RB, Dorea JG, Barbosa F Jr, Aschner M, Rocha JB, Farina M: Comparative study on methyl- and ethylmercury-induced toxicity in C6 glioma cells and the potential role of LAT-1 in mediating mercurial-thiol complexes uptake. Neurotoxicology 2013, 38: 1-8.","journal-title":"Neurotoxicology"},{"key":"50_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/02772240802246458","volume":"91","author":"DA Geier","year":"2009","unstructured":"Geier DA, King PG, Geier MR: Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure to Thimerosal and other metal compounds. Toxicol Environ Chem 2009, 91: 735-749. 10.1080\/02772240802246458","journal-title":"Toxicol Environ Chem"},{"key":"50_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jns.2008.04.002","volume":"271","author":"HA Young","year":"2008","unstructured":"Young HA, Geier DA, Geier MR: Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci 2008, 271: 110-118. 10.1016\/j.jns.2008.04.002","journal-title":"J Neurol Sci"},{"key":"50_CR27","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1080\/15287394.2010.519317","volume":"73","author":"CM Gallagher","year":"2010","unstructured":"Gallagher CM, Goodman MS: Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997\u20132002. J Toxicol Environ Health A 2010, 73: 1665-1677. 10.1080\/15287394.2010.519317","journal-title":"J Toxicol Environ Health A"},{"key":"50_CR28","first-page":"401","volume":"27","author":"DA Geier","year":"2006","unstructured":"Geier DA, Geier MR: A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro Endocrinol Lett 2006, 27: 401-413.","journal-title":"Neuro Endocrinol Lett"},{"key":"50_CR29","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/jama.290.13.1763","volume":"290","author":"A Hviid","year":"2003","unstructured":"Hviid A, Stellfeld M, Wohlfahrt J, Melbye M: Association between Thimerosal-containing vaccine and autism. JAMA 2003, 290: 1763-1766. 10.1001\/jama.290.13.1763","journal-title":"JAMA"},{"key":"50_CR30","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1542\/peds.2003-1177-L","volume":"114","author":"N Andrews","year":"2004","unstructured":"Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B: Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004, 114: 584-591. 10.1542\/peds.2003-1177-L","journal-title":"Pediatrics"},{"key":"50_CR31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1542\/peds.112.2.e98","volume":"112","author":"T Verstraeten","year":"2003","unstructured":"Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT: Vaccine safety datalink team. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintance organization databases. Pediatrics 2003, 112: 1039-1048.","journal-title":"Pediatrics"},{"key":"50_CR32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/archpedi.1996.02170300018004","volume":"150","author":"RT Chen","year":"1996","unstructured":"Chen RT, Rosenthal S: An errant critique that misses the mark. Arch Pediatr Adlesc Med 1996, 150: 464-465. 10.1001\/archpedi.1996.02170300018004","journal-title":"Arch Pediatr Adlesc Med"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-9158-2-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T23:15:48Z","timestamp":1716333348000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/2047-9158-2-25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["50"],"URL":"https:\/\/doi.org\/10.1186\/2047-9158-2-25","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"article-number":"25"}}